C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina
- PMID: 11849862
- DOI: 10.1016/s0735-1097(01)01804-6
C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina
Abstract
Objectives: The objective of this study was to determine the prognostic value of C-reactive protein (CRP) independent of coronary angiographic findings.
Background: High sensitivity CRP, a marker of inflammation, predicts risk of cardiovascular events. However, it is uncertain whether it remains predictive once angiographic findings are considered.
Methods: A total of 2,554 patients with angina but without acute myocardial infarction (MI) were studied angiographically; 1,848 patients had coronary artery disease (CAD) and 706 patients did not. Coronary artery disease was quantified in five ways and combined for a CAD score. C-reactive protein was measured and patients were followed for up to five years for death or MI.
Results: C-reactive protein correlated with the extent of CAD, but correlation coefficients were low (0.02 to 0.08). Of angiographic measures, the CAD score best predicted future events (hazard ratio [HR] = 1.8 [1.2 to 2.6], p = 0.004, for CAD score > 4). C-reactive protein > or = 1.0 mg/dl was predictive in both patients without CAD (HR = 2.3 [0.9 to 5.5], p = 0.07) and with CAD (HR = 2.1 [1.5 to 3.1], p = 0.0001). Multivariate adjustment resulted in little change in HR. C-reactive protein retained predictive value within each quintile of CAD score. C-reactive protein and CAD independently and additively contributed to the risk prediction: low CRP and lowest CAD score was associated with lowest risk, and high CRP and highest CAD score was associated with the highest risk, with a 10-fold difference between extremes (2.5% vs. 24%).
Conclusions: C-reactive protein correlates with extent of CAD, but the degree of correlation is low. Severity/extent of CAD and CRP are independent and additive predictors of risk. Therapy should target CRP-associated risk as well as angiographically evident stenosis.
Similar articles
-
Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency?J Am Coll Cardiol. 2003 Jul 2;42(1):57-63. doi: 10.1016/s0735-1097(03)00564-3. J Am Coll Cardiol. 2003. PMID: 12849660
-
Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease.Atherosclerosis. 2009 May;204(1):239-43. doi: 10.1016/j.atherosclerosis.2008.08.009. Epub 2008 Aug 15. Atherosclerosis. 2009. PMID: 18823889
-
Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study).Clin Chim Acta. 2015 May 20;445:93-100. doi: 10.1016/j.cca.2015.03.029. Epub 2015 Mar 27. Clin Chim Acta. 2015. PMID: 25818243
-
New Modifiable Risk Factors Influencing Coronary Artery Disease Severity.Int J Mol Sci. 2024 Jul 16;25(14):7766. doi: 10.3390/ijms25147766. Int J Mol Sci. 2024. PMID: 39063008 Free PMC article. Review.
-
High-sensitivity C-reactive protein and cardiovascular risk in patients with coronary heart disease.Curr Opin Cardiol. 2002 Jul;17(4):325-31. doi: 10.1097/00001573-200207000-00001. Curr Opin Cardiol. 2002. PMID: 12151864 Review.
Cited by
-
Is pentraxin 3 a biomarker, a player, or both in the context of coronary atherosclerosis and metabolic factors?Heart Vessels. 2015 Nov;30(6):752-61. doi: 10.1007/s00380-014-0553-0. Epub 2014 Jul 22. Heart Vessels. 2015. PMID: 25048680
-
Association between Resting Heart Rate and Inflammatory Markers (White Blood Cell Count and High-Sensitivity C-Reactive Protein) in Healthy Korean People.Korean J Fam Med. 2017 Jan;38(1):8-13. doi: 10.4082/kjfm.2017.38.1.8. Epub 2016 Jan 18. Korean J Fam Med. 2017. PMID: 28197327 Free PMC article.
-
Total cholesterol content of erythrocyte membranes is associated with the severity of coronary artery disease and the therapeutic effect of rosuvastatin.Ups J Med Sci. 2012 Nov;117(4):390-8. doi: 10.3109/03009734.2012.672345. Epub 2012 Sep 25. Ups J Med Sci. 2012. PMID: 23009223 Free PMC article.
-
Chemokine RANTES is increased at early stages of coronary artery disease.J Physiol Pharmacol. 2016 Apr;67(2):321-8. J Physiol Pharmacol. 2016. PMID: 27226191 Free PMC article.
-
Biomarkers of chronic inflammatory state in uremia and cardiovascular disease.Int J Inflam. 2012;2012:360147. doi: 10.1155/2012/360147. Epub 2012 Jun 4. Int J Inflam. 2012. PMID: 22701810 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous